• About
  • Subscribe
  • Advertise
  • Contact
Thursday, July 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Older Australians need our support

by Staff Writer
January 10, 2017
in Research
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

What the report really highlighted was, that despite these benefits, there are barriers to accessing low vision aids in this country particularly for those most in need – the 100,000 older Australians with permanent vision loss and blindness.The major barrier is cost.For over a decade, responsibility for a funded equipment program of aids and technologies has been shuffled between state and federal governments; numerous portfolios in health, ageing and disabilities, and finally; falling between the gaps of aged care and disability reforms.{{quote-A:R-W:450-Q:The vast majority of Australians dealing with sight loss have great difficulty affording or accessing these aids. This needs to change.}}Fragmented services, inadequate referral pathways, and inadequate co-managent plans between eyecare practitioners and low vision services are other barriers to access, along with poor consumer information and knowledge regarding services.Lost amongst this tangle of bureaucracy, buck passing and ignorance, is the fact that low vision aids can transform the lives of people with sight loss. It might be as simple as a magnifier or specialised lighting, but it can help people lead fulfilling, independent lives.However, the vast majority of Australians dealing with sight loss have great difficulty affording or accessing these aids. This needs to change.So, while successive governments should be commended for subsidising registered sight saving drugs to avoid vision loss, unfortunately many older Australians who are vision impaired or blind are repeatedly missing out on the support they most need – low vision aids and technologies.The Foundation’s new report documents the value and effectiveness of low vision aids and technologies, the barriers to access, and the reasons why this issue must be placed firmly on the government agenda. Recommendations proposed in the report are financially achievable and the Foundation is already discussing with Ministers ways to provide older Australians locked out of the NDIS both the funding and the support they so desperately need.Initial cost estimates undertaken by the Foundation for a federally funded program indicated that the cost of implentation and evaluation could be as little at $30 million per year. This includes a suggested allowance of $667–2,400 per person per annum, depending on vision assessment.The report strongly recommends:

  • Investment in research to accurately quantify the impact low vision aids, technologies and services can have on quality of life and independence.
  • The establishment of a nationally funded, accessible, affordable and consistent low vision aids and equipment program to replace the current state/territory government programs.
  • That financial support for aids, donstrated to improve quality of life for people with functional vision loss, is established in private health insurance policies.

While we wait for our own government to prioritise low vision and blindness as a health priority, the World Health Organisation is presently establishing an international standard of services for low vision rehabilitation. We hope that this will provide an important benchmark for minimum services in Australia.In the meantime, Macular Disease Foundation Australia will continue its efforts to keep this issue on the government agenda – but we could always use help.As mbers, leaders and influencers of the eyecare sector, it’s up to all of us to ensure every Australian in need enjoys greater independence and quality of life afforded through access to low vision aids and technologies.SHIRLEY’S STORY“My vision rapidly deteriorated from AMD. I couldn’t read the newspaper anymore and I couldn’t even watch television because the rote control became too difficult to use. When I think about it now, I was depressed. The world seed to be closing in around me.”Shirley contacted the Foundation who was able to spend the time to discuss the low vision and community services available. The Foundation arranged for Shirley to subscribe to Vision Australia’s audio-book library services and also to access a large button TV rote control.“On the first day I had my audio-book player I listened to the Herald and then I started to listen to a book. I didn’t move all day! I cannot describe how this simple piece of technology that I can easily use has changed my life and my outlook on life. I just feel happier and more engaged with the world.”


Name: Julie HeraghtyQualifications: BA, DipEd, Assoc MAPSOrganisation: Macular Disease Foundation AustraliaPosition: CEOLocation: SydneyYears in the profession: 13 years as CEO of MDFA

 

Related Posts

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

If you are not enjoying what you are doing or not looking forward to heading into work, that is one sign of stress and anxiety, says
Dr Anne Malatt. Image: Andrii/stock.adobe.com.

Special Report: Seeing everyone but themselves – mental health and eye surgery

by Rob Mitchell
July 6, 2026

Stress, anxiety and burnout remain hidden challenges in ophthalmology. Two practitioners bring that out into the open and talk about...

Figure 1 shows population coverage, defined as the number of people served per full-time-equivalent optometrist. Image: Dr Matt Trinh.

Soapbox: Maldistribution not the biggest problem in optometry

by Dr Matt Trinh
July 1, 2026

Australia’s optometry workforce debate often defaults to maldistribution and the idea that we have enough optometrists but in the wrong...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited